Immunotherapy of metastatic malignant melanoma by a vaccine consisting of autologous interleukin 2-transfected cancer cells: outcome of a phase I study.
Schreiber S, Kämpgen E, Wagner E, Pirkhammer D, Trcka J, Korschan H, Lindemann A, Dorffner R, Kittler H, Kasteliz F, Küpcü Z, Sinski A, Zatloukal K, Buschle M, Schmidt W, Birnstiel M, Kempe RE, Voigt T, Weber HA, Pehamberger H, Mertelsmann R, Bröcker EB, Wolff K, Stingl G.
Schreiber S, et al. Among authors: buschle m.
Hum Gene Ther. 1999 Apr 10;10(6):983-93. doi: 10.1089/10430349950018382.
Hum Gene Ther. 1999.
PMID: 10223732
Clinical Trial.